Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
4Pwj1m25VZMcNc87
Listen
